Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Compare Efficacy and Safety Between Quetiapine and Haloperidol in Treatment Delirium.

Next Previous
Trial Profile

Compare Efficacy and Safety Between Quetiapine and Haloperidol in Treatment Delirium.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Sep 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Quetiapine (Primary) ; Haloperidol
  • Indications Delirium
  • Focus Therapeutic Use

Most Recent Events

  • 07 Sep 2011 Interim results (n=38) presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
  • 22 Jun 2011 Planned end date changed from 1 Jul 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov
  • 22 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top